COLLEGIUM PHARMACEUTICAL, INC
For the period ended May 12, 2026. Filed May 12, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 12, 2026 · Filed May 12, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · IMPORTANT SAFETY INFORMATION
IMPORTANT SAFETY INFORMATION
BOXED WARNING: ABUSE, MISUSE, AND ADDICTION See full prescribing information for complete boxed warning. AZSTARYS has a high potential for abuse, misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including AZSTARYS, can result in overdose and death. – Before prescribing, assess each patient’s risk for abuse, misuse, and addiction. – Educate patients and families about risks, proper storage, and proper disposal of any unused drug. – Frequently monitor for signs and symptoms of abuse, misuse, and addiction throughout treatment.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.